{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:54:26Z","timestamp":1772643266099,"version":"3.50.1"},"reference-count":31,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2021,4,30]]},"DOI":"10.5582\/ddt.2021.01035","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T22:12:43Z","timestamp":1619647963000},"page":"73-77","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of pathogenicity and therapeutic effectiveness of antibiotics using silkworm &lt;i&gt;Nocardia&lt;\/i&gt; infection model"],"prefix":"10.5582","volume":"15","author":[{"given":"Kazuhiro","family":"Mikami","sequence":"first","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, Tokyo, Japan."},{"name":"Drug Discoveries by Silkworm Models, Faculty of Pharma-Science, Teikyo University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Sonobe","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tokyo Medical and Dental University Medical Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Ishino","sequence":"additional","affiliation":[{"name":"Division of Infection Control Sciences, Department of Clinical Pharmacy, School of Pharmacy, Showa University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Hanao","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hamamoto","sequence":"additional","affiliation":[{"name":"Teikyo University Institute of Medical Mycology, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Sekimizu","sequence":"additional","affiliation":[{"name":"Drug Discoveries by Silkworm Models, Faculty of Pharma-Science, Teikyo University, Tokyo, Japan."},{"name":"Genome Pharmaceuticals Institute, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ, Jr. Clinical and laboratory features of the <i>Nocardia<\/i> spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006; 19:259-282.","DOI":"10.1128\/CMR.19.2.259-282.2006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Williams E, Jenney AW, Spelman DW. <i>Nocardia<\/i> bacteremia: A single-center retrospective review and a systematic review of the literature. Int J Infect Dis. 2020; 92:197-207.","DOI":"10.1016\/j.ijid.2020.01.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fatahi-Bafghi M. Nocardiosis from 1888 to 2017. Microb Pathog. 2018; 114:369-384.","DOI":"10.1016\/j.micpath.2017.11.012"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Boiron P, Provost F, Chevrier G, Dupont B. Review of nocardial infections in France 1987 to 1990. Eur J Clin Microbiol Infect Dis. 1992; 11:709-714.","DOI":"10.1007\/BF01989975"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Poonwan N, Mekha N, Yazawa K, Thunyaharn S, Yamanaka A, Mikami Y. Characterization of clinical isolates of pathogenic <i>Nocardia<\/i> strains and related actinomycetes in Thailand from 1996 to 2003. Mycopathologia. 2005; 159:361-368.","DOI":"10.1007\/s11046-005-1045-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gonzalez-Carrillo C, Millan-Sauceda C, Lozano-Garza HG, Ortiz-Lopez R, Elizondo-Gonzalez R, Welsh O, Ocampo-Candiani J, Vera-Cabrera L. Genomic changes associated with the loss of <i>Nocardia<\/i> <i>brasiliensis<\/i> virulence in mice after 200 <i>in vitro<\/i> passages. Infect Immun. 2016; 84:2595-2606.","DOI":"10.1128\/IAI.00329-16"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Desmond EP, Flores M. Mouse pathogenicity studies of <i>Nocardia<\/i> <i>asteroides<\/i> complex species and clinical correlation with human isolates. FEMS Microbiol Lett. 1993; 110:281-284.","DOI":"10.1111\/j.1574-6968.1993.tb06335.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gombert ME, Berkowitz LB, Aulicino TM, duBouchet L. Therapy of pulmonary nocardiosis in immunocompromised mice. Antimicrob Agents Chemother. 1990; 34:1766-1768.","DOI":"10.1128\/AAC.34.9.1766"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gombert ME, Aulicino TM, duBouchet L, Silverman GE, Sheinbaum WM. Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline. Antimicrob Agents Chemother. 1986; 30:270-273.","DOI":"10.1128\/AAC.30.2.270"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hamamoto H, Sekimizu K. Identification of lysocin E using a silkworm model of bacterial infection. Drug Discov Ther. 2016; 10:24-29.","DOI":"10.5582\/ddt.2016.01012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Panthee S, Paudel A, Hamamoto H, Sekimizu K. Advantages of the silkworm as an animal model for developing novel antimicrobial agents. Front Microbiol. 2017; 8:373.","DOI":"10.3389\/fmicb.2017.00373"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hamamoto H, Kurokawa K, Kaito C, Kamura K, Manitra Razanajatovo I, Kusuhara H, Santa T, Sekimizu K. Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms. Antimicrob Agents Chemother. 2004; 48:774-779.","DOI":"10.1128\/AAC.48.3.774-779.2004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Matsumoto Y, Miyazaki S, Fukunaga DH, Shimizu K, Kawamoto S, Sekimizu K. Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with <i>Cryptococcus neoformans<\/i>. J Appl Microbiol. 2012; 112:138-146.","DOI":"10.1111\/j.1365-2672.2011.05186.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yagi A, Yamazaki H, Terahara T, Yang T, Hamamoto H, Imada C, Tomoda H, Uchida R. Development of an <i>in vivo<\/i>-mimic silkworm infection model with <i>Mycobacterium avium<\/i> complex. Drug Discov Ther. 2021; 14:287-295.","DOI":"10.5582\/ddt.2020.03099"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hosoda K, Koyama N, Hamamoto H, Yagi A, Uchida R, Kanamoto A, Tomoda H. Evaluation of anti-mycobacterial compounds in a silkworm infection model with <i>Mycobacteroides abscessu<\/i>s. Molecules. 2020; 25:4971.","DOI":"10.3390\/molecules25214971"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yagi A, Uchida R, Hamamoto H, Sekimizu K, Kimura KI, Tomoda H. Anti-mycobacterium activity of microbial peptides in a silkworm infection model with <i>Mycobacterium smegmatis<\/i>. J Antibiot (Tokyo). 2017; 70:685-690.","DOI":"10.1038\/ja.2017.23"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Baker GC, Smith JJ, Cowan DA. Review and re-analysis of domain-specific 16S primers. J Microbiol Methods. 2003; 55:541-555.","DOI":"10.1016\/j.mimet.2003.08.009"},{"key":"18","unstructured":"18. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Eighth edition CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, Pa, 2012."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tan YE, Chen SC, Halliday CL. Antimicrobial susceptibility profiles and species distribution of medically relevant <i>Nocardia<\/i> species: Results from a large tertiary laboratory in Australia. J Glob Antimicrob Resist. 2020; 20:110-117.","DOI":"10.1016\/j.jgar.2019.06.018"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nakamura I, Nagakura T, Fujita H, Fukusima S, Gonoi T. <i>Nocardia<\/i> <i>elegans<\/i> infection: a case report and literature review. Int J Infect Dis. 2017; 54:15-17.","DOI":"10.1016\/j.ijid.2016.10.031"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kato K, Noguchi S, Naito K, Ikushima I, Hanaka T, Yamasaki K, Kawanami T, Yatera K. Pulmonary nocardiosis caused by <i>Nocardia<\/i> <i>exalbida<\/i> in a patient with lung cancer and radiation pneumonitis: A case report and literature review. Intern Med. 2019; 58:1605-1611.","DOI":"10.2169\/internalmedicine.2177-18"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gombert ME, Aulicino TM. Synergism of imipenem and amikacin in combination with other antibiotics against <i>Nocardia asteroides<\/i>. Antimicrob Agents Chemother. 1983; 24:810-811.","DOI":"10.1128\/AAC.24.5.810"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Paudel A, Hamamoto H, Panthee S, Matsumoto Y, Sekimizu K. Large-scale screening and identification of novel pathogenic Staphylococcus aureus genes using a silkworm infection model. J Infect Dis. 2020; 221:1795-1804.","DOI":"10.1093\/infdis\/jiaa004"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Paudel A, Panthee S, Hamamoto H, Grunert T, Sekimizu K. YjbH regulates virulence genes expression and oxidative stress resistance in <i>Staphylococcus aureus<\/i>. Virulence. 2021; 12:470-480.","DOI":"10.1080\/21505594.2021.1875683"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kaito C, Kurokawa K, Matsumoto Y, Terao Y, Kawabata S, Hamada S, Sekimizu K. Silkworm pathogenic bacteria infection model for identification of novel virulence genes. Mol Microbiol. 2005; 56:934-944.","DOI":"10.1111\/j.1365-2958.2005.04596.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Miyazaki S, Matsumoto Y, Sekimizu K, Kaito C. Evaluation of <i>Staphylococcus aureus<\/i> virulence factors using a silkworm model. FEMS Microbiol Lett. 2012; 326:116-124.","DOI":"10.1111\/j.1574-6968.2011.02439.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ishii K, Adachi T, Hara T, Hamamoto H, Sekimizu K. Identification of a <i>Serratia marcescens <\/i>virulence factor that promotes hemolymph bleeding in the silkworm, <i>Bombyx mori<\/i>. J Invertebr Pathol. 2014; 117:61-67.","DOI":"10.1016\/j.jip.2014.02.001"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Miyashita A, Iyoda S, Ishii K, Hamamoto H, Sekimizu K, Kaito C. Lipopolysaccharide O-antigen of enterohemorrhagic <i>Escherichia coli<\/i> O157:H7 is required for killing both insects and mammals. FEMS Microbiol Lett. 2012; 333:59-68.","DOI":"10.1111\/j.1574-6968.2012.02599.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Folb PI, Jaffe R, Altmann G. <i>Nocardia asteroides<\/i> and <i>Nocardia brasiliensis<\/i> infections in mice. Infect Immun. 1976; 13:1490-1496.","DOI":"10.1128\/IAI.13.5.1490-1496.1976"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gomez-Flores A, Welsh O, Said-Fernandez S, Lozano-Garza G, Tavarez-Alejandro RE, Vera-Cabrera L. <i>In vitro<\/i> and <i>in vivo<\/i> activities of antimicrobials against <i>Nocardia<\/i> <i>brasiliensis<\/i>. Antimicrob Agents Chemother. 2004; 48:832-837.","DOI":"10.1128\/AAC.48.3.832-837.2004"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Daw-Garza A, Welsh O, Said-Fernandez S, Lozano-Garza HG, Waksman de Torres N, Rocha NC, Ocampo-Candiani J, Vera-Cabrera L. <i>In vivo<\/i> therapeutic effect of gatifloxacin on BALB\/c mice infected with <i>Nocardia<\/i> <i>brasiliensis<\/i>. Antimicrob Agents Chemother. 2008; 52:1549-1550.","DOI":"10.1128\/AAC.00148-08"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/15\/2\/15_2021.01035\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T04:01:01Z","timestamp":1621051261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/15\/2\/15_2021.01035\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2021.01035","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]}}}